# Mario Negri Institute for Pharmacological Research

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/mario-negri-institute-for-pharmacological-research/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74.8 |
| Citations | 5,406,427 |
| City | Milan |
| Country | IT |
| Description | Mario Negri Institute for Pharmacological Research is a research organisation in Milan, IT. OpenAlex records 20,758 works and 5,406,427 citations for it. 2,622 researchers list it as their most recent affiliation. |
| Homepage | http://www.marionegri.it/en_US/home |
| OpenAlex ID | https://openalex.org/I19630809 |
| Researchers | 2,622 |
| ROR ID | https://ror.org/05aspc753 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q3803751 |
| Works | 20,758 |

## University papers

Showing 12 of 89.

- [Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/effects-of-losartan-on-renal-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-3/)
- [A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure](https://scholariq.org/papers/a-randomized-trial-of-the-angiotensin-receptor-blocker-valsartan-in-chronic/)
- [Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group](https://scholariq.org/papers/lung-adjuvant-cisplatin-evaluation-a-pooled-analysis-by-the-lace-collaborative/)
- [Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials](https://scholariq.org/papers/statins-and-risk-of-incident-diabetes-a-collaborative-meta-analysis-of/)
- [A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/a-trial-of-darbepoetin-alfa-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency](https://scholariq.org/papers/ferric-carboxymaltose-in-patients-with-heart-failure-and-iron-deficiency/)
- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [The Seattle Heart Failure Model](https://scholariq.org/papers/the-seattle-heart-failure-model/)
- [Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II](https://scholariq.org/papers/effect-of-losartan-compared-with-captopril-on-mortality-in-patients-with/)
- [Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial](https://scholariq.org/papers/comparison-of-carvedilol-and-metoprolol-on-clinical-outcomes-in-patients-with/)
- [The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1](https://scholariq.org/papers/the-clinicopathologic-spectrum-of-focal-cortical-dysplasias-a-consensus/)

## University researchers

- [Giuseppe Remuzzi](https://scholariq.org/researchers/giuseppe-remuzzi/)
- [Norberto Perico](https://scholariq.org/researchers/norberto-perico/)

## University top topics

Showing 8 of 25.

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.